Evidence map›Paper›PMID 29447845›Full record

ArticleNeuropharmacology2018

Probing GABA

Sandra Seljeset, Damian P Bright, Philip Thomas, Trevor G Smart

Open access · hybridAbstract read
In one paragraph

Article in Neuropharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Activation of TRPA1 and TRPM3 triggers CaThe Journal of physiology · 2025
    Article
  3. New directions in neurosteroid therapeutics in neuropsychiatry.Neuroscience and biobehavioral reviews · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Neurosteroid enantiomers as potentially novel neurotherapeutics.Neuroscience and biobehavioral reviews · 2023
    Review
  8. Allosteric modulation of α1β3γ2 GABABiophysical journal · 2023
    Article
  9. Article
  10. Physiological role for GABANature communications · 2021
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sandra SeljesetDepartment of Neuroscience, Physiology & Pharmacology, UCL, Gower Street, London, WC1E 6BT, United Kingdom.
Damian P BrightDepartment of Neuroscience, Physiology & Pharmacology, UCL, Gower Street, London, WC1E 6BT, United Kingdom.
Philip ThomasDepartment of Neuroscience, Physiology & Pharmacology, UCL, Gower Street, London, WC1E 6BT, United Kingdom.
Trevor G SmartDepartment of Neuroscience, Physiology & Pharmacology, UCL, Gower Street, London, WC1E 6BT, United Kingdom. Electronic address: t.smart@ucl.ac.uk.
University College London · GB

Funding

Medical Research Council MR/K005537/1Wellcome Trust
6 · The paper itself

Abstract

γ-aminobutyric acid type A receptors (GABA

Indexed as

AnimalsBinding SitesCell LineHumansMembrane PotentialsMiceNeurotransmitter AgentsPentobarbitalPicrotoxinPregnenoloneProtein DomainsReceptors, GABA-ARecombinant ProteinsNeurotransmitter AgentsPentobarbitalPicrotoxinPregnenoloneReceptors, GABA-ARecombinant ProteinsGABAGABA-A receptorInhibitionNeurosteroidsPregnenolone sulphate

Identifiers

PMID29447845
PMCPMC6018617
OpenAlexW2790907647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.